Cohance Lifesciences has announced the issuance of a compliance certificate under SEBI regulations for the quarter ending December 31, 2025. The certificate confirms compliance with depositories and participants regulations and was provided by KFin Technologies Limited, the Registrar and Share Transfer Agent for Cohance Lifesciences. This announcement ensures shareholders and stakeholders of the company’s adherence to regulatory requirements.
Compliance Confirmation
Cohance Lifesciences has received confirmation of compliance with regulatory standards for the quarter ending December 31, 2025. This confirmation comes in the form of certificates issued by KFin Technologies Limited.
Details of Compliance
The compliance certification, as stated in the company’s official announcement, relates to the SEBI (Depositories and Participants) Regulations, 2018. KFin Technologies Limited, acting as the Registrar and Share Transfer Agent, has verified and confirmed adherence to these regulations for the specified quarter.
Source: BSE
